← Back to Treatments
🏅 FDA Orphan Designation

DUVYZAT

GIVINOSTAT

Manufacturer: Italfarmaco SPA

Indicated for:
Duchenne and Becker muscular dystrophyOrphanDuchenne muscular dystrophyOrphan

FDA-Approved Indications (2)

treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older

Duchenne muscular dystrophyOrphan Designation

1 INDICATIONS AND USAGE DUVYZAT is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older. DUVYZAT is a histone deacetylase inhibitor indicated for the t…

Indications & Usage

1 INDICATIONS AND USAGE DUVYZAT is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older. DUVYZAT is a histone deacetylase inhibitor indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older. ( 1 )

💙 Support Programs

View all →
DUVYZAT
Italfarmaco
Copay card ↗Apply ↗

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.